In most systems, bad data is a wrong number. In a hospital, it is a misdiagnosis, a missed allergy, a wrong dose. Observability is how you catch silent data failures before they reach the patient.
Treat clinical data quality like any warehouse and the cost of a missed failure is not a re-run, it is a patient, discovered after the harm is done.
Apply real-time observability across the five pillars plus end-to-end lineage so failures are caught before they reach a clinical decision.
In a clinical context each pillar maps to a specific patient-safety risk. Freshness: is this lab result current, or is a stale value shown as live
When a clinical value is wrong, lineage answers the two questions that matter most: where did it come from, and which patients and decisions has it already touched.
The value of clinical decision support AI hinges entirely on the quality of the data feeding it. A model reasoning over stale or wrong inputs produces confident, wrong guidance.
Identify the feeds that reach clinical decisions: labs, vitals, meds, device streams, and the EHR, plus the conversions between them. Monitor these first.
Put freshness, volume, schema, and distribution monitoring on those feeds, with alerting fast enough to act before a decision is made.
Trace every clinical value to its source and forward to every chart and decision it touches, for root cause and downstream impact.
When something breaks, alert the owner with the affected patients and the auditable provenance HIPAA requires.
The data is growing 36% a year, still entered largely by hand, feeding decisions where a stale lab or mis-converted medication field can harm someone.
The pillars are the same; the stakes and the latency requirement are not. In patient-critical systems you must catch issues before a clinical decision, not in the next batch report, and lineage's downstream-impact question is "which patients," not "which dashboards."
Because CDS AI's safety hinges on data quality. AI on unobserved clinical data scales bad inputs into more decisions. Observability is the prerequisite.
Yes. End-to-end lineage provides the transparent, auditable record of data provenance that HIPAA and clinical governance require, so the capability that protects patients also satisfies the auditor.
Largely manual entry and handwritten notes, plus duplication, data loss, EHR conversions, and device-feed anomalies, all of which fail silently.
Real-time monitoring with lineage, so a bad value is caught before it reaches a decision and, if it slips through, you can immediately find every patient it affected.
